Evidence map›Paper›PMID 35436041›Full record

ArticleMicrobial biotechnology2022

Identification of genome integration sites for developing a CRISPR-based gene expression toolkit in Yarrowia lipolytica.

Xiaoqin Liu, Zhiyong Cui, Tianyuan Su, Xuemei Lu, Jin Hou, Qingsheng Qi

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. EngineeringSynthetic and systems biotechnology · 2026
    Article
  3. Efficient production of astaxanthin inSynthetic and systems biotechnology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Genetic tools for metabolic engineering ofEngineering microbiology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. A review of synthetic biology tools in Yarrowia lipolytica.World journal of microbiology & biotechnology · 2023
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoqin LiuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.ORCID 0000-0003-2032-0805
Zhiyong CuiState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.
Tianyuan SuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.ORCID 0000-0001-5758-2927
Xuemei LuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.
Jin HouState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.ORCID 0000-0001-6789-6057
Qingsheng QiState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.
Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of synthetic biology, the oleaginous yeast Yarrowia lipolytica has become an attractive microorganism for chemical production. To better optimize and reroute metabolic pathways, we have expanded the CRISPR-based gene expression toolkit of Y. lipolytica. By sorting the integration sites associated with high expression, new neutral integration sites associated with high expression and high integration efficiency were identified. Diverse genetic components, including promoters and terminators, were also characterized to expand the expression range. We found that in addition to promoters, the newly characterized terminators exhibited large variations in gene expression. These genetic components and integration sites were then used to regulate genes involved in the lycopene biosynthesis pathway, and different levels of lycopene production were achieved. The CRISPR-based gene expression toolkit developed in this study will facilitate the genetic engineering of Y. lipolytica.

Indexed as

YarrowiaCRISPR-Cas SystemsGene ExpressionLycopeneMetabolic EngineeringLycopene

Identifiers

PMID35436041
PMCPMC9328735
OpenAlexW4224031447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.